CC-90011
Showing 26 - 50 of 791
Smoking, Cigarette, Electronic Cigarette Use Trial in Providence (Cue Reactivity Task, Computerized Visual Dot Probe, Choice
Recruiting
- Smoking, Cigarette
- Electronic Cigarette Use
- Cue Reactivity Task
- +2 more
-
Providence, Rhode IslandCenter for Alcohol and Addiction Studies
Jan 30, 2023
Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)
Recruiting
- Multiple Myeloma
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 21, 2023
Lupus Erythematosus, Systemic Trial in Berlin (CC-97540, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Lupus Erythematosus, Systemic
- CC-97540
- +2 more
-
Berlin, GermanyLocal Institution - 0025
May 22, 2023
Sentinel Lymph Node Biopsy, MRI Trial in Wenzhou (ICG/ blue dye)
Enrolling by invitation
- Sentinel Lymph Node Biopsy
- MRI
- ICG/ blue dye
-
Wenzhou, Zhejiang, ChinaThe 2nd Affiliated Hospital and Yuying Children's Hospital of WM
Jul 3, 2023
Community-Based Chronic Disease Care in Rural Lesotho
Not yet recruiting
- Non-communicable Diseases (NCDs)
-
Maseru, Lesotho
- +1 more
Nov 29, 2022
Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
Recruiting
- Human Papilloma Virus
- +3 more
-
Jerusalem, IsraelHadassah Medical Center
Dec 6, 2022
Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in
Completed
- Endometrial Cancer
- Cervical Cancer
- Indocyanine green-guided systematic pelvic lymphadenectomy
- (no location specified)
Jan 29, 2023
Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL) Trial in Canada, United States (CC-97540)
Active, not recruiting
- Lymphoma Non-Hodgkin
- +2 more
- CC-97540
-
Birmingham, Alabama
- +13 more
Oct 28, 2022
Heart Arrest, Birth Asphyxia, Bradycardia Trial in Austria, Canada (CC+SI, 3:1 C:V)
Recruiting
- Heart Arrest
- +2 more
- CC+SI
- 3:1 C:V
-
Graz, Austria
- +3 more
Jun 9, 2022
Smoking Cessation, Harm Reduction Trial in Charlotte, Raleigh (d-cycloserine, Juul e-cigarette)
Not yet recruiting
- Smoking Cessation
- Harm Reduction
- d-cycloserine
- Juul e-cigarette
-
Charlotte, North Carolina
- +1 more
Aug 8, 2023
Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)
Active, not recruiting
- Hematologic Neoplasm
- Neoplasms
-
Gainesville, Florida
- +2 more
Jan 12, 2023
Long-term Clinical Response to BoNT in Cervical Dystonia
Not yet recruiting
- Cervical Dystonia
- CC BoNT/A
- +3 more
-
Düsseldorf, North Rhine-Westphalia, GermanyDüsseldorf University Hospital
May 22, 2023
Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in
Not yet recruiting
- Inflammatory Bowel Diseases
- +3 more
- Diagnostic Test
-
Nashville, TennesseeMeharry Medical College
Dec 15, 2022
Uncover Subtypes of Cancer Cachexia, LOTUS-CC Study
Recruiting
- Cancer Cachexia (CC)
-
Urbana, Illinois
- +4 more
Oct 3, 2023
Disease Recurrence After Curative Surgery for Stage I Colon
Recruiting
- Colon Cancer Stage I
- Colon Cancer
- Colonic resection
-
Paris, France
- +23 more
Feb 16, 2023
Colorectal Cancer, Colorectal Adenoma, Colorectal Tumors Trial in Denmark (AI-assisted colonoscopy)
Recruiting
- Colorectal Cancer
- +2 more
- AI-assisted colonoscopy
-
Holbæk, Denmark
- +3 more
Feb 21, 2023
Heart Failure, Hemodialysis Trial in Tehran (Empagliflozin10Mg Tab)
Recruiting
- Heart Failure
- Hemodialysis
- Empagliflozin10Mg Tab
-
Tehran, Iran, Islamic Republic ofNooshin Dalili
Jul 21, 2023
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (CC-92480, Carfilzomib, Dexamethasone)
Recruiting
- Relapsed or Refractory Multiple Myeloma
- CC-92480
- +2 more
-
Mobile, Alabama
- +130 more
Jan 27, 2023
Hypertension Trial (Telemedicine-based WHO HEARTS package)
Not yet recruiting
- Hypertension
- Telemedicine-based WHO HEARTS package
- (no location specified)
Jul 13, 2023
